<p></p><p>The active metabolite of vitamin A, retinoic acid, is a key mediator
of balanced immune responses. The major nuclear receptor of retinoic acid,
retinoic receptor alpha (RARα), functions as a transcriptional regulator, with
both active and repressive effects on transcription depending on interactions
with nuclear cofactors dictated by ligand-binding effects on protein
confirmation. While significant advances have been made in understanding the
combined effects of retinoic acid and RARα, the individual roles of each remain
incompletely identified.</p>
<p> Epigenetic
effects of all-trans retinoic acid (At-RA) and RARα on the transcriptome of T
helper cells were assessed using a novel transgenic mouse strain designed to
overexpress RARα in T cells and a conditional knock out strain in which RARα was
specifically deleted from T cells. At-RA and RARα had divergent roles in
promoting Th17 and Treg differentiation, with RARα expression favoring Th17
differentiation over Treg differentiation, and At-RA promoting Treg
differentiation over Th17 differentiation. Transcriptome analysis identified
groups of At-RA and RARα differentially regulated genes (DEGs). Comparison of
these genes to the H3k27 acetylated and tri-methylated epigenetic modifications
demonstrated that RARα expression increased the overall level of these
epigenetic modifications in all DEG groups, with enhanced control of
transcriptional regulation mediated by higher RARα expression. Additionally, expression
of transcriptional repressors was
strongly regulated by At-RA in a RARα-dependent manner and had repressive
effects on the differentiation of T helper cells. </p>
<p> Immunometabolism
was also enhanced by RARα expression, leading us to study potential non-genomic
roles of RARα on signaling pathways. The major TCR signaling pathways were
enhanced by RARα but suppressed by At-RA, suggesting a mechanism by which RARα
regulates cellular metabolism upon T cell activation. </p>
<p> In summary,
we identified distinct epigenetic and non-genomic effects of RARα as novel
regulatory mechanisms by which vitamin A and retinoic acid influence immune
responses. Further research into these findings, notably RARα involvement in
signal transduction pathways of immune cells, will define how this research can
be translated into clinically-relevant applications.</p><br><p></p>